Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amplitude effects on electrocochleography outcomes.

David Hough1, R Stanley Baker

  • 1Hough Ear Institute, 3400 Northwest 56th Street, Oklahoma City, OK 73112, U.S.A. houghear@swbell.net

The Laryngoscope
|September 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder.

Annals of general psychiatry·2023
Same author

Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2021
Same author

Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression.

Clinical pharmacology and therapeutics·2020
Same author

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).

The international journal of neuropsychopharmacology·2020
Same author

Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I).

The Journal of clinical psychiatry·2020
Same author

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2).

The Journal of clinical psychiatry·2020

Electrocochleography (ECoG) is more reliable for diagnosing hearing loss when the action potential (AP) from click stimulation exceeds 1 microV. This threshold ensures accurate correlation between click and tone-evoked measures in ECoG analysis.

Area of Science:

  • Audiology
  • Neurophysiology
  • Otolaryngology

Background:

  • Electrocochleography (ECoG) is a diagnostic tool used to assess auditory function.
  • Accurate ECoG measures are crucial for diagnosing hearing disorders.

Purpose of the Study:

  • To investigate factors influencing the reliability of human electrocochleography results.
  • To determine the optimal conditions for obtaining accurate ECoG measures.

Main Methods:

  • A retrospective analysis of 479 patients undergoing tympanic membrane electrocochleography between 1998 and 2002.
  • Comparison of click-evoked electrocochleography (summating potential to action potential ratio [SP/AP]) with tone-evoked electrocochleography (SP amplitude).

Main Results:

Related Experiment Videos

  • A significant correlation between click and tone measures was observed when the action potential (AP) amplitude from click stimulation was greater than 1 microV (P <.001).
  • No significant correlation was found if the AP amplitude was less than 1 microV.
  • Results were further analyzed based on patient hearing sensitivity and diagnosis.

Conclusions:

  • Tympanic membrane electrocochleography demonstrates increased efficacy when the action potential (AP) from click stimulation surpasses 1 microV.
  • This finding provides a critical threshold for reliable ECoG interpretation in clinical audiology.